BMRA News

Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution

The Boston Globe to Host Rare Disease Summit

Biomerica Reports Second Quarter Fiscal 2026 Financial Results